Manufacturing

Sep 18, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration has issued two warning letters to Ranbaxy Laboratories.
Sep 11, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, Human Genome Sciences enters pact with Hospira, Zosano Pharma names Gail Schulze chair and CEO, more...
Sep 11, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
FDA has issued a Final Rule titled "Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals."
Sep 11, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration has updated its draft bioequivalence recommendations for several products, and added 66 new draft product-specific guidelines since October 2007.
Sep 11, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
The US Food and Drug Administration launched a new website to educate the general public about direct-to-consumer (DTC) advertising of prescription medications.
Sep 04, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, Novartis stops development on "Aurograb," Zealand Pharma appoints David H. Solomon as CEO, more...
Sep 04, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Companies launched 25 new active substances in 2007, a decline of 19% from the previous year, according to a new report from Parexel International.
Sep 03, 2008
PTSM: Pharmaceutical Technology Sourcing and Management
The pharmaceutical majors deploy green-chemistry strategies to improve the synthesis of active pharmaceutical ingredients and intermediates.
Sep 03, 2008
PTSM: Pharmaceutical Technology Sourcing and Management
The US Food and Drug Administration will hold a public meeting this month to gain public input on implementing the recommendations of the Nanotechnology Task Force report, taking another step closer to setting a regulatory framework for nanotechnology for pharmaceuticals and medical devices.
Sep 02, 2008
Pharmaceutical Technology
Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?
native1_300x100
lorem ipsum